Anaphylaxis is a severe, life-threatening allergic reaction. While epinephrine auto-injectors like the EpiPen have been the standard treatment for years, fear of needles or difficulty with administration can cause delays. Neffy, an epinephrine nasal spray, offers a needle-free option for emergency allergy care.
The Innovation Behind Neffy
Neffy was approved by the FDA in August 2024 as the first needle-free anaphylaxis treatment. Developed by ARS Pharmaceuticals, it delivers epinephrine through the nasal lining, achieving rapid absorption similar to auto-injectors. Intravail technology aids this process, enhancing nasal absorption.
How to Use Neffy
Neffy is administered in two steps. For self-administration, the device is held with the thumb on the plunger and fingers on the sides of the nozzle. The nozzle is inserted into one nostril, and the plunger is pressed until it clicks. Avoid sniffing deeply during or after use. Call 911 immediately after use and note the time. A second dose in the same nostril can be given after 5 minutes if symptoms persist. More detailed instructions can be found on {Link: Drug Topics https://www.drugtopics.com/view/fda-approves-first-needle-free-epinephrine-nasal-spray}.
Why a Needle-Free Option Matters
Needle-free options like Neffy offer several benefits over injectables, including reducing anxiety related to needles, simplifying administration, potentially increasing compliance due to portability, and increasing availability through programs like NeffyinSchools.
Clinical Evidence and Considerations
Clinical trials in healthy adults showed Neffy produced similar blood epinephrine levels and increases in blood pressure and heart rate as auto-injectors. However, real-world data from anaphylaxis episodes is still needed as studies on individuals experiencing anaphylaxis are not ethically possible. Patients with nasal issues or sulfite allergy should consult an allergist. Emergency medical care is required after any anaphylactic episode.
Other Emerging Needle-Free Options
Researchers are exploring other needle-free options, such as an epinephrine film that dissolves under the tongue (Anaphylm) and intranasal epinephrine in powder form. A comparison of different treatments is available on {Link: Drug Topics https://www.drugtopics.com/view/fda-approves-first-needle-free-epinephrine-nasal-spray}.
Conclusion
Neffy provides a significant needle-free alternative for anaphylaxis treatment. This nasal spray is user-friendly and may lead to quicker administration by reducing anxiety. While auto-injectors remain important, Neffy expands treatment options for patients and caregivers. Always consult an allergist for the best treatment plan and seek emergency medical attention after using any epinephrine product. This advancement improves accessibility in emergency allergy care.
Additional Resources
For further information on Neffy and anaphylaxis, consult resources from organizations like the American Academy of Allergy, Asthma & Immunology and the Allergy & Asthma Network, or visit the official Neffy website. ARS Pharmaceuticals - Neffy